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bacteria, which allows distinguishing between different strains of
the pathogen isolated from TB patients.
Methods & Materials: During 2014 the 93 cases of TB were
studied in patients who were treated in hospitals in Kharkiv region
in Ukraine. Mycobacterium identiﬁcation and testing of the drug
susceptibility were performed as recommended by WHO. The
samples of expectoration were used for the strain isolation on
Lowenstein-Jensen medium. VNTR genotyping was done by using
sets of primers for ampliﬁcation of ﬁve exact tandem repeat ETR
loci as previously described (Frothingham, R., 1998).
Results: It hasbeen shown that 69% from isolatedM. tuberculosis
strains belong to Beijing family whereas 13% –to LAM. Other geno-
types consisted 18% from all obtained isolates. The most common
proﬁle was 42435.
The most common resistance among Beijing strains were
observed to streptomycin (100%), followed by resistance to isoni-
azid (99%), rifampicin (96%) and ethambutol (89%). Kanamycin and
oﬂoxacin did not inhibit growth of M. tuberculоsis isolates in 69%
and 60% cases respectively. The most effective anti-TB drug was
cycloserine (10%). Among LAM strains it was found resistance to
kanamycin, isoniazid and streptomycin in 12 (100%) cases, etham-
butol and rifampicin – in 11 (91.5%) cases.
The frequency of resistance to kanamycin, 4-Aminosalicylic acid
and ethionamide was revealed signiﬁcantly higher for LAM strain
in compare to Beijing strain (p <0.05). 41 (44%) of 93 patients were
diagnosed as MDR TB and 52 (56%) – TB with extending resistance.
Conclusion: In conclusion, the data showed that TB in Kharkiv
region is mostly characterized as multi-drug resistance cases. To
prevent circulation and transmission of M.tuberculosis TB control
program needs to be improved in Ukraine.
http://dx.doi.org/10.1016/j.ijid.2016.02.241
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Background: Microorganisms though dimunuitive are
formidable foes. The antibiotic soup that now permeates health-
care facilities has exerted a selection pressure on pathogens and
commensal organisms alike, and resistance has proliferated and
spread such that many bacteria can withstand almost all drugs.
Detection of -lactamases by virtue of their diverse complex-
ity is a diagnostic dilemma hindered by the heterogeneity of both
host and enzyme. Expression of multiple -lactamases and their
co-existence is a common parlance particularly in nosocomial
pathogens which are notorious for disseminating them compro-
mising the therapeutic alternatives. When faced with this mélange
of enzymes in resource constraint settings lack or inadequacy of
diagnostic tests may have grave implications.
Methods & Materials: 168 clinical isolates E.coli (n =53)
K.pneumoniae (n =115) from invasive site infections were studied
for their antimicrobial susceptibility and detection of -lactamase
by inhibitor based disc potentiation test (DPT). A total of 18 agents
of which 6 were substrate inhibitor combination discs were tested
per isolate. Detection of ESBL, MBL, AmpC and KPC was done by
using inhibitors- EDTA, Dipicolinic acid (DCA), Phenyl boronic acid
(PBA), Clavulanic acid (CA) and cloxacillin(CLOX). Appropriate con-
trols were incorporated.
Results: High resistance to all classes of cephalosporins was
observed inall isolates. Carbapenemresistancewas found in87.15%
isolates. Least resistance to cotrimoxazole andgentamicinwas seen
among the antimicrobials tested. ESBL was the most frequent 
lactamase detected followed by MBL>AmpC>KPC.
Conclusion: We are living in a world where we will never be
able to stay ahead of the bacterial mutation curve. A test of our
resilience is how far behind the curve we allow ourselves to fall.
Limiteddata is availableonpresenceofKPC’s in India andnone from
our region. There is a need for enhanced adherence with effective
infection control measures, detect and protect strategy and antibi-
otic stewardship to curb patient-to-patient transmission and to
reduce the selection of multidrug-resistant bacteria. Currently the
main issues are providing practical recommendations ondetection,
treatment and prevention in different resources settings.
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